Page 196 - Assessing right ventricular function and the pulmonary circulation in pulmonary hypertension Onno Anthonius Spruijt

11
[23] Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Critical care (London, England). 2010; 14:R169
[24] Zamanian RT, Haddad F, Doyle RL, Weinacker AB. Management strategies for patients with pulmonary hypertension in the intensive care unit. Critical care medicine. 2007; 35:2037-50
[25] Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. The Journal of clinical investigation. 1992; 89:803-15
[26] Piao L, Fang YH, Parikh KS, Ryan JJ, D'Souza KM, Theccanat T, et al. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension. Circulation. 2012; 126:2859-69
[27] Sharma T, Lau EM, Choudhary P, Torzillo PJ, Munoz PA, Simmons LR, et al. Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension. The European respiratory journal. 2015; 45:700-8
[28] Guihaire J, Haddad F, Noly PE, Boulate D, Decante B, Dartevelle P, et al. Right ventricular reserve in a piglet model of chronic pulmonary hypertension. The European respiratory journal. 2015; 45:709-17
[29] Acosta F, Sansano T, Palenciano CG, Falcon L, Domenech P, Robles R, et al. Effects of dobutamine on right ventricular function and pulmonary circulation in pulmonary hypertension during liver transplantation. Transplantation proceedings. 2005; 37:3869-70